Pneumonia Testing Market Size, Share & Trends by 2034

Coverage: By Method (Immunodiagnostics, Molecular Diagnostics, Point of Care (POC) Testing); Technology (Enzyme-linked Immunosorbent Assay (ELISA), Immunofluorescence, Western Blot, Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), Others); Type (Analyzers, Consumables); End User (Hospitals, Diagnostic Laboratories, Homecare, Others) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPRE00004719
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : April 09, 2026
Pneumonia Testing Market Size, Share & Trends by 2034
Report Date: April 09, 2026   |   Report Code: TIPRE00004719 Email: sales@theinsightpartners.com
Buy Now

2025 Market Size

US$ 2.53 Bn

Base year value

2034 Forecast

US$ 5.52 Bn

Projected by 2034

CAGR 2026-2034

9.06 %

Growth rate

Addressable Market

US$ 36.02 Bn

(2026-2034)

Pneumonia Testing market size is expected to reach US$ 5.52 Billion by 2034 from US$ 2.53 Billion in 2025. The market is anticipated to register a CAGR of 9.06% during the forecast period 2026–2034.

The Pneumonia Testing Market is categorized by method into Immunodiagnostics, Molecular Diagnostics, and Point of Care (POC) Testing. It also breaks down by technology, i.e., Enzyme-linked Immunosorbent Assay (ELISA), Immunofluorescence, Western Blot, Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), and Others, and type, including Analyzers and Consumables. Projections up to 2031 provide insights into how pneumonia testing innovations impact productivity and customer satisfaction. The global analysis is broken down at the regional level and major countries. The market evaluation is presented in US$ for the above segmental analysis.

Purpose of the Report

The report Pneumonia Testing Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Pneumonia Testing Market Segmentation Method

  1. Immunodiagnostics
  2. Molecular Diagnostics
  3. Point of Care Testing

Technology

  1. Enzyme-linked Immunosorbent Assay
  2. Immunofluorescence
  3. Western Blot
  4. Polymerase Chain Reaction
  5. Immunohistochemistry
  6. Others

Type

  1. Analyzers
  2. Consumables

End User

  1. Hospitals
  2. Diagnostic Laboratories
  3. Homecare
  4. Others

Market Research Highlights

  • Global market for Pneumonia Testing was valued at US$ 2.53 Billion in 2025
  • Annual market size is expected to reach US$ 5.52 Billion by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 36.02 Billion
  • Market is anticipated to register a CAGR of 9.06% during the forecast period
  • The United States represents a key market, supported by Rising Pneumonia Case, Advances in Molecular Diagnostics, Growing Healthcare Awareness, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Growth in Emerging Markets, Development of Rapid Testing Products, New Preoccupation with Antibiotic Resistance are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including Thermo Fisher Scientific Inc., Abbott., F-Hoffmann la Roche Ltd., Hologic Inc., bioMerieux SA, BD, Bio-Rad Laboratories Inc., OpGen., Quest Diagnostics Incorporated, Quidel., Meridian Biosciences, Quest Diagnostics, AdvanDx, Beckman Coulter, Cepheid, Concile, Diamedix, DiaSorin, Fast-track Diagnostics, SeraCare, Trinity Biotech, while analyzing competitive strategies and innovation developments

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Pneumonia Testing Market: Strategic Insights

pneumonia-testing-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Pneumonia Testing Market Growth Drivers

  1. Rising Pneumonia Case: Pneumonia still remains at the top of the leading causes of death worldwide, mostly in younger children, elderly individuals, or those whose immunity system is badly affected. Increasing incidence of cases in the world is driven by major factors like respiratory infections and air pollution along with seasonal epidemics, and it greatly demands highly efficient testing methods for pneumonia.
  2. Advances in Molecular Diagnostics: Molecular diagnostic technologies, such as PCR (Polymerase Chain Reaction) and next-generation sequencing, provide very accurate and fast results for the identification of pathogens causing pneumonia. This is gradually replacing the traditional culture-based methods, thereby allowing earlier diagnosis and more effective treatment.
  3. Growing Healthcare Awareness: Healthcare awareness is increasing about pneumonia and early detection and diagnosis, and hence demand for diagnostics. More so in developing countries, this awareness is driving the market to spend more money on the new diagnostic tools.

Pneumonia Testing Market Future Trends

  1. Point-of-Care Testing: The point-of-care (POC) trend is spreading in the pneumonia testing industry. Small, portable test kits are helping doctors diagnose pneumonia accurately and quickly in a distant or resource-poor environment.
  2. Integration of Molecular Diagnostics: The increasing use of molecular diagnostic tests (PCR and next generation sequencing) are increasing the sensitivity and specificity of the pneumonia tests. This is broadening the test palette.
  3. Development in Digital Health Products: Digital health products incorporating pneumonia testing in the digital health records (EHRs) and telemedicine are trending. These devices help to diagnose faster and better manage patients in places that are hard to reach.

Pneumonia Testing Market Opportunities

  1. Growth in Emerging Markets: The demand for pneumonia testing products would expand in emerging economies as the healthcare system is increasing and infectious diseases are on the rise. This is a huge market opportunity.
  2. Development of Rapid Testing Products: There is ample time for businesses to develop quick, accurate and affordable testing products for pneumonia. In quick turnaround times, effective patient care leaves very little time and so this brings huge opportunity in the developed as well as emerging market.
  3. New Preoccupation with Antibiotic Resistance: Pneumonia from antibiotic resistant bacteria is on the rise. Resistance markers offer a possibility for new diagnostic tests to prescribe better treatment programmes and ultimately benefit patients.

Pneumonia Testing Market Report Scope

Report Attribute Details
Market size in 2025 US$ 2.53 Billion
Market Size by 2034 US$ 5.52 Billion
Global CAGR (2026 - 2034) 9.06%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Method
  • Immunodiagnostics
  • Molecular Diagnostics
  • Point of Care Testing
By Technology
  • Enzyme-linked Immunosorbent Assay
  • Immunofluorescence
  • Western Blot
  • Polymerase Chain Reaction
  • Immunohistochemistry
  • Others
By Type
  • Analyzers
  • Consumables
By End User
  • Hospitals
  • Diagnostic Laboratories
  • Homecare
  • Others
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Thermo Fisher Scientific Inc.
  • Abbott.
  • F-Hoffmann la Roche Ltd.
  • Hologic Inc.
  • bioMerieux SA
  • BD
  • Bio-Rad Laboratories Inc.
  • OpGen.
  • Quest Diagnostics Incorporated
  • Quidel.
  • Meridian Biosciences
  • Quest Diagnostics
  • AdvanDx
  • Beckman Coulter
  • Cepheid

Pneumonia Testing Market Players Density: Understanding Its Impact on Business Dynamics

The Pneumonia Testing Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

pneumonia-testing-market-cagr

Key Selling Points

  1. Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Pneumonia Testing Market, providing a holistic landscape.
  2. Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  3. Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  4. Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Pneumonia Testing Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

Key trends in the market include shift to molecular diagnostic tools, integration of point-of-care testing, and rising demand for rapid testing solutions.

Key companies in this market are- Thermo Fisher Scientific Inc., Abbott., F-Hoffmann la Roche Ltd., Hologic Inc., bioMerieux SA, BD, Bio-Rad Laboratories Inc., OpGen., Quest Diagnostics Incorporated, Quidel,

The market is expected to register a CAGR of 9.06% from 2026 to 2034

Some of the key drivers include increase in pneumonia cases, advancements in diagnostic technologies, and rising healthcare awareness.
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA